Michigan Medicine oncologists highlight some of the top findings that came from the field’s largest professional meeting.
For the first time, researchers have found an important factor that mitigates immune suppression in cancer.
Tissue and blood samples taken from patients can hold the keys to biomedical discovery. But the research community must consider patient privacy, a new perspective says.
With a new president, what happens to the Cancer Moonshot? And how likely is it to succeed, anyway?
Changes in epigenetics suggest a predictive marker for childhood ependymomas and similarities with DIPG tumors.
Roughly 1 in 50 promising cancer drug candidates makes it to market. What’s holding the other 49 back?